Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases: an outcome analysis of a pooled multi-platform patient cohort

Background - Local treatment of metastases in combination with systemic therapy can prolong survival of oligo-metastasized patients. To fully exploit this potential, safe and effective treatments are needed to ensure long-term metastases control. Stereotactic body radiotherapy (SBRT) is one means, h...

Full description

Saved in:
Bibliographic Details
Main Authors: Stera, Susanne (Author) , Miebach, Georgia (Author) , Bürgy, Daniel (Author) , Dreher, Constantin (Author) , Lohr, Frank (Author) , Wurster, Stefan (Author) , Rödel, Claus (Author) , Marcella, Szücs (Author) , Krug, David (Author) , Frank A., Giordano (Author) , Ehmann, Michael (Author) , Fleckenstein, Jens (Author) , Blanck, Oliver (Author) , Boda-Heggemann, Judit (Author)
Format: Article (Journal)
Language:English
Published: May 2021
In: Radiotherapy and oncology
Year: 2021, Volume: 158, Pages: 230-236
ISSN:1879-0887
DOI:10.1016/j.radonc.2021.02.036
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.radonc.2021.02.036
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0167814021061107
Get full text
Author Notes:Susanne Stera, Georgia Miebach, Daniel Buergy, Constantin Dreher, Frank Lohr, Stefan Wurster, Claus Rödel, Szücs Marcella, David Krug, Giordano Frank A., Michael Ehmann, Jens Fleckenstein, Oliver Blanck, Judit Boda-Heggemann

MARC

LEADER 00000caa a2200000 c 4500
001 1770893083
003 DE-627
005 20240414193350.0
007 cr uuu---uuuuu
008 210917s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.radonc.2021.02.036  |2 doi 
035 |a (DE-627)1770893083 
035 |a (DE-599)KXP1770893083 
035 |a (OCoLC)1341421332 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Stera, Susanne  |e VerfasserIn  |0 (DE-588)1241353344  |0 (DE-627)1770892214  |4 aut 
245 1 0 |a Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases  |b an outcome analysis of a pooled multi-platform patient cohort  |c Susanne Stera, Georgia Miebach, Daniel Buergy, Constantin Dreher, Frank Lohr, Stefan Wurster, Claus Rödel, Szücs Marcella, David Krug, Giordano Frank A., Michael Ehmann, Jens Fleckenstein, Oliver Blanck, Judit Boda-Heggemann 
264 1 |c May 2021 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.09.2021 
520 |a Background - Local treatment of metastases in combination with systemic therapy can prolong survival of oligo-metastasized patients. To fully exploit this potential, safe and effective treatments are needed to ensure long-term metastases control. Stereotactic body radiotherapy (SBRT) is one means, however, for moving liver tumors correct delivery of high doses is challenging. After validating equal in-vivo treatment accuracy, we analyzed a pooled multi-platform liver-SBRT-database for clinical outcome. - Methods - Local control (LC), progression-free interval (PFI), overall survival (OS), predictive factors and toxicity was evaluated in 135 patients with 227 metastases treated by gantry-based SBRT (deep-inspiratory breath-hold-gating; n = 71) and robotic-based SBRT (fiducial-tracking, n = 156) with mean gross tumor volume biological effective dose (GTV-BEDα/β=10Gy) of 146.6 Gy10. - Results - One-, and five-year LC was 90% and 68.7%, respectively. On multivariate analysis, LC was significantly predicted by colorectal histology (p = 0.006). Median OS was 20 months with one- and two-year OS of 67% and 37%. On multivariate analysis, ECOG-status (p = 0.003), simultaneous chemotherapy (p = 0.003), time from metastasis detection to SBRT-treatment (≥2months; p = 0.021) and LC of the treated metastases (≥12 months, p < 0.009) were significant predictors for OS. One- and two-year PFI were 30.5% and 14%. Acute toxicity was mild and rare (14.4% grade I, 2.3% grade II, 0.6% grade III). Chronic °III/IV toxicities occurred in 1.1%. - Conclusions - Patient selection, time to treatment and sufficient doses are essential to achieve optimal outcome for SBRT with active motion compensation. Local control appears favorable compared to historical control. Long-term LC of the treated lesions was associated with longer overall survival. 
650 4 |a Active motion management 
650 4 |a CyberKnife 
650 4 |a Deep inspiration breath hold 
650 4 |a Liver SBRT 
650 4 |a Robotic tracking 
700 1 |a Miebach, Georgia  |d 1995-  |e VerfasserIn  |0 (DE-588)1241353743  |0 (DE-627)1770892834  |4 aut 
700 1 |a Bürgy, Daniel  |d 1980-  |e VerfasserIn  |0 (DE-588)141653779  |0 (DE-627)630406472  |0 (DE-576)325119031  |4 aut 
700 1 |a Dreher, Constantin  |d 1991-  |e VerfasserIn  |0 (DE-588)1075340934  |0 (DE-627)833201387  |0 (DE-576)44340805X  |4 aut 
700 1 |a Lohr, Frank  |e VerfasserIn  |0 (DE-588)1025307194  |0 (DE-627)72201967X  |0 (DE-576)37018694X  |4 aut 
700 1 |a Wurster, Stefan  |d 1970-  |e VerfasserIn  |0 (DE-588)121419460  |0 (DE-627)081294476  |0 (DE-576)292699530  |4 aut 
700 1 |a Rödel, Claus  |d 1966-  |e VerfasserIn  |0 (DE-588)1152978330  |0 (DE-627)101434705X  |0 (DE-576)499988248  |4 aut 
700 1 |a Marcella, Szücs  |e VerfasserIn  |4 aut 
700 1 |a Krug, David  |e VerfasserIn  |0 (DE-588)1062940202  |0 (DE-627)807054747  |0 (DE-576)420297944  |4 aut 
700 1 |a Frank A., Giordano  |e VerfasserIn  |4 aut 
700 1 |a Ehmann, Michael  |d 1978-  |e VerfasserIn  |0 (DE-588)140496491  |0 (DE-627)618903615  |0 (DE-576)318527715  |4 aut 
700 1 |a Fleckenstein, Jens  |d 1981-  |e VerfasserIn  |0 (DE-588)102911918X  |0 (DE-627)732477212  |0 (DE-576)376584599  |4 aut 
700 1 |a Blanck, Oliver  |e VerfasserIn  |0 (DE-588)115998106X  |0 (DE-627)1023098768  |0 (DE-576)505430649  |4 aut 
700 1 |a Boda-Heggemann, Judit  |d 1977-  |e VerfasserIn  |0 (DE-588)1029853436  |0 (DE-627)734363087  |0 (DE-576)377699411  |4 aut 
773 0 8 |i Enthalten in  |t Radiotherapy and oncology  |d Amsterdam [u.a.] : Elsevier Science, 1983  |g 158(2021) vom: Mai, Seite 230-236  |h Online-Ressource  |w (DE-627)306710110  |w (DE-600)1500707-8  |w (DE-576)082435731  |x 1879-0887  |7 nnas  |a Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases an outcome analysis of a pooled multi-platform patient cohort 
773 1 8 |g volume:158  |g year:2021  |g month:05  |g pages:230-236  |g extent:7  |a Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases an outcome analysis of a pooled multi-platform patient cohort 
856 4 0 |u https://doi.org/10.1016/j.radonc.2021.02.036  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0167814021061107  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210917 
993 |a Article 
994 |a 2021 
998 |g 1029853436  |a Boda-Heggemann, Judit  |m 1029853436:Boda-Heggemann, Judit  |d 60000  |d 63000  |e 60000PB1029853436  |e 63000PB1029853436  |k 0/60000/  |k 1/60000/63000/  |p 14  |y j 
998 |g 102911918X  |a Fleckenstein, Jens  |m 102911918X:Fleckenstein, Jens  |d 60000  |d 63000  |e 60000PF102911918X  |e 63000PF102911918X  |k 0/60000/  |k 1/60000/63000/  |p 12 
998 |g 140496491  |a Ehmann, Michael  |m 140496491:Ehmann, Michael  |d 60000  |d 63000  |e 60000PE140496491  |e 63000PE140496491  |k 0/60000/  |k 1/60000/63000/  |p 11 
998 |g 1075340934  |a Dreher, Constantin  |m 1075340934:Dreher, Constantin  |d 60000  |d 63000  |e 60000PD1075340934  |e 63000PD1075340934  |k 0/60000/  |k 1/60000/63000/  |p 4 
998 |g 141653779  |a Bürgy, Daniel  |m 141653779:Bürgy, Daniel  |d 60000  |d 63000  |e 60000PB141653779  |e 63000PB141653779  |k 0/60000/  |k 1/60000/63000/  |p 3 
998 |g 1241353743  |a Miebach, Georgia  |m 1241353743:Miebach, Georgia  |d 60000  |d 63000  |e 60000PM1241353743  |e 63000PM1241353743  |k 0/60000/  |k 1/60000/63000/  |p 2 
999 |a KXP-PPN1770893083  |e 3979101460 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","given":"Susanne","display":"Stera, Susanne","family":"Stera"},{"family":"Miebach","display":"Miebach, Georgia","given":"Georgia","role":"aut"},{"display":"Bürgy, Daniel","family":"Bürgy","given":"Daniel","role":"aut"},{"given":"Constantin","role":"aut","display":"Dreher, Constantin","family":"Dreher"},{"display":"Lohr, Frank","family":"Lohr","role":"aut","given":"Frank"},{"display":"Wurster, Stefan","family":"Wurster","given":"Stefan","role":"aut"},{"role":"aut","given":"Claus","family":"Rödel","display":"Rödel, Claus"},{"role":"aut","given":"Szücs","family":"Marcella","display":"Marcella, Szücs"},{"display":"Krug, David","family":"Krug","given":"David","role":"aut"},{"role":"aut","given":"Giordano","display":"Frank A., Giordano","family":"Frank A."},{"family":"Ehmann","display":"Ehmann, Michael","role":"aut","given":"Michael"},{"display":"Fleckenstein, Jens","family":"Fleckenstein","role":"aut","given":"Jens"},{"display":"Blanck, Oliver","family":"Blanck","given":"Oliver","role":"aut"},{"given":"Judit","role":"aut","display":"Boda-Heggemann, Judit","family":"Boda-Heggemann"}],"language":["eng"],"note":["Gesehen am 17.09.2021"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"May 2021"}],"title":[{"title_sort":"Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases","subtitle":"an outcome analysis of a pooled multi-platform patient cohort","title":"Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1770893083","relHost":[{"language":["eng"],"part":{"text":"158(2021) vom: Mai, Seite 230-236","extent":"7","volume":"158","year":"2021","pages":"230-236"},"titleAlt":[{"title":"The green journal"}],"recId":"306710110","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["306710110"],"issn":["1879-0887"],"zdb":["1500707-8"]},"title":[{"subtitle":"journal of the European Society for Therapeutic Radiology and Oncology","title_sort":"Radiotherapy and oncology","title":"Radiotherapy and oncology"}],"pubHistory":["1.1983 -"],"note":["Gesehen am 30.05.15","Ungezählte Beil.: Supplement"],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1983-","publisher":"Elsevier Science","dateIssuedKey":"1983"}],"disp":"Liver SBRT with active motion-compensation results in excellent local control for liver oligometastases an outcome analysis of a pooled multi-platform patient cohortRadiotherapy and oncology","type":{"media":"Online-Ressource","bibl":"periodical"}}],"name":{"displayForm":["Susanne Stera, Georgia Miebach, Daniel Buergy, Constantin Dreher, Frank Lohr, Stefan Wurster, Claus Rödel, Szücs Marcella, David Krug, Giordano Frank A., Michael Ehmann, Jens Fleckenstein, Oliver Blanck, Judit Boda-Heggemann"]},"physDesc":[{"extent":"7 S."}],"id":{"eki":["1770893083"],"doi":["10.1016/j.radonc.2021.02.036"]}} 
SRT |a STERASUSANLIVERSBRTW2021